drugset / Trial / NCT07266259

Effect of Levocarnitine Plus Myoinositol Versus Myoinositol Alone on Hormonal and Insulin Resistance in PCOS Women

NCT07266259

Recruiting 72 enrolled Mst.Sumyara Khatun
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to learn if combination of levocarnitine and myoinositol works better than myoinositol alone on insulin resistance and hormonal parameters in subfertile women with insulin resistant polycystic ovary syndrome . It will also learn about the safety of drug levocarnitine and myoinositol. The main questions it aims to answer are: Does combined action of levocarnitine and myoinositol improve insulin resistance and hormonal parameters in comparison to myoinositol alone in subfertile women with insulin resistant polycystic ovary syndrome ? What medical problems do participants have when taking drug levocarnitine and myoinositol? Researchers will compare the drug combination of levocarnitine and myoinositol to myoinositol alone to see if combination therapy works better? Participants will: Take drug levocarnitine and myoinositol or a myoinositol alone twice daily for 3 months Visit the clinic once after 3 months for checkups and tests Keep a diary of their symptoms and the number of times.

Timeline

Start
2025-09-19
Primary completion
2026-08-18
Completion
2027-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Inositol Small molecule 750 mg
Subject L-carnitine Other / unclassified 330 mg